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Background
There are a number of challenges in the development of
an effective vaccine for HIV, including stimulation of
potent and broad cellular and humoral immune response
that can cross protect between strains or clades. We have
studied the cellular immune response, using genomics, of
a DNA based vaccine that resulted in potent and broad
cellular immune responses that suppressed SIV251 repli-
cation.
Methods
Rhesus macaques were immunized 4 times with 1.5 mg of
optimized SIVmac239 DNA vaccines, delivered by electro-
poration. Two groups of macaques received, along with
vaccine, molecular adjuvants RANTES or IL-12. Macaques
were challenged by the interrectal route, with high dose,
unmatched SIVmac251. PBMCs were isolated and
assessed by standard ELISPOT and proliferation methods
for vaccine specific responses. PBMCs were also stimu-
lated with vaccine antigens and RNA was isolated for func-
tional genomics analysis.
Results
The most extraordinary result was that the RANTES mole-
cule dampened the vaccine specific peripheral immune
responses as assessed by antigen specific IFN-gamma pro-
duction and proliferation but had a more significant
impact on viral load compared to the DNA alone group.
Using array analysis, the expression profiles of the differ-
ent vaccine groups was compared. We found by ANOVA
approximately 400 of 15,230 genes had altered expression
in a vaccine specific manner compared to the control
group. The gene expression levels were reflective of what
was observed in biological assays. In addition, a func-
tional genomics analysis of a second DNA vaccine study
has now demonstrated using a rank-order analysis the
same network of altered gene expression.
Conclusion
This is the first demonstration of an antigen specific
response to a vaccine utilizing genomics. And this study
provides a number of new immunological markers that
may be relevant to vaccine analysis. This data that may be
beneficial in providing guidance for future vaccinations
regimens.
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